M
Matthew E.J. Callister
Researcher at Leeds Teaching Hospitals NHS Trust
Publications - 96
Citations - 3415
Matthew E.J. Callister is an academic researcher from Leeds Teaching Hospitals NHS Trust. The author has contributed to research in topics: Lung cancer & Lung cancer screening. The author has an hindex of 20, co-authored 73 publications receiving 2455 citations. Previous affiliations of Matthew E.J. Callister include Leeds General Infirmary & St James's University Hospital.
Papers
More filters
Journal ArticleDOI
British Thoracic Society guidelines for the investigation and management of pulmonary nodules: accredited by NICE
Matthew E.J. Callister,David R Baldwin,Ahsan R. Akram,S Barnard,Paul Cane,J. Draffan,Kevin Franks,Fergus V. Gleeson,Richard Graham,P Malhotra,Mathias Prokop,K. Rodger,Manil Subesinghe,David A. Waller,Ian Woolhouse +14 more
TL;DR: This guideline is based on a comprehensive review of the literature on pulmonary nodules and expert opinion and provides more clarity in the use of further imaging and more clarity about the place of biopsy.
British Thoracic Society guidelines for the investigation and management of pulmonary nodules.
Matthew E.J. Callister,David R Baldwin,Ahsan R. Akram,S. Barnard,Paul Cane,J. Draffan,Kevin Franks,Fergus V. Gleeson,Richard Graham,P Malhotra,Mathias Prokop,K. Rodger,Manil Subesinghe,David A. Waller,Ian Woolhouse +14 more
TL;DR: The British Thoracic Society guideline for the investigation and management of pulmonary nodules is published as a supplement to this edition of the journal.
Journal ArticleDOI
British Thoracic Society guidelines for the investigation and management of pulmonary nodules.
TL;DR: The British Thoracic Society guideline for the investigation and management of pulmonary nodules is published as a supplement to this edition of the journal as discussed by the authors, which provides recommendations for the management of an individual with single or multiple pulmonary nodule and is a comprehensive reference text.
Journal ArticleDOI
European position statement on lung cancer screening
Matthijs Oudkerk,Anand Devaraj,Rozemarijn Vliegenthart,Thomas Henzler,Helmut Prosch,Claus P. Heussel,Claus P. Heussel,Gorka Bastarrika,Nicola Sverzellati,Mario Mascalchi,Stefan Delorme,David R Baldwin,Matthew E.J. Callister,Nikolaus Becker,Marjolein A Heuvelmans,Witold Rzyman,Maurizio Infante,Ugo Pastorino,Jesper Holst Pedersen,Eugenio Paci,Stephen W. Duffy,Harry J. de Koning,John K. Field +22 more
TL;DR: A risk stratification approach should be used for future lung cancer low-dose CT programmes and patients should be provided with information on the benefits and harms of screening to ensure that patients receive the most appropriate treatment.
Journal ArticleDOI
Thioredoxin: friend or foe in human disease?
TL;DR: The role of Trx in human disease is reviewed and related to its redox activity and biological properties, and the development and use of therapies that either inhibit or augment Trx activity are discussed.